About US
Contact us
-
Novartis to pay $50M, lose some drug coverage in Korean bribery probeFor more than a year, Novartis has been under investigation in Korea for allegedly bribing doctors to pump up sales. Now, the Swiss drug giant is learning about its punishment in the country as author2017/5/16
-
J&J, Bayer face first jury trial over blockbuster Xarelto's bleeding risksThe first federal trial over the bleeding risks of Xarelto, Johnson & Johnson and Bayer’s blockbuster anticoagulant, kicks off next week, with 18,000 more cases stacked up behind it. It will be th2017/5/16
-
What if EpiPen price hikes were designed to crush rivals? Sanofi suit claims that, and much moreMylan landed in hot water with its EpiPen pricing and marketing on Capitol Hill, at the U.S. Justice Department, with New York’s attorney general and in investor class-action lawsuits. It’s beentarget2017/5/15
-
Big Pharma faces $26.5B in losses this year as next big patent cliff looms, analyst saysWith 18 branded drugs on the line, patent losses this year could jeopardize$26.5 billion in annual sales from Big Pharma,projected to be the biggest fall-off until at least 2025, according to Bernstei2017/5/15
-
Pfizer subpoenaed to testify in DOJ's antitrust probe of saline shortagesPfizer and ICU Medical, which recently bought the Hospira Infusion Systems business from Pfizer, both acknowledged on Wednesday that they have been caught up in the Justice Department’sinvestigation i2017/5/12
-
Amgen, already on PCSK9 offense, slaps Sanofi, Regeneron with Dupixent patent suitLast month, Sanofi and Regeneron sued Amgen in a move tofend offa nasty patent court battle over their new atopic dermatitis drug Dupixent. After all, the two companies were already fighting Amgen to2017/5/12
-
Ashland will acquire Pharmachem Laboratories Inc.Ashland Global Holdings Inc. ASH, -1.39% a specialty chemicals company serving a range of consumer and industrial markets, said Mondya that it will acquire Pharmachem Laboratories Inc. for $660 millio2017/4/18
-
Takeda and NuBiyota to develop microbial ecosystem therapeutic products for GI indicationsJapanese company Takeda Pharmaceutical Company is all set to collaborate with NuBiyota to develop microbial ecosystem therapeutic products for gastroenterology (GI) indications. Under the partnership2017/4/18
-
Appili to develop new antibiotic to treat gram-negative infectionsAnti-infective drug development company Appili Therapeutics is set to receive funding to support the development of a new antibiotic to treat gram-negative infections. The additional $400,000 funding2017/4/17
-
Austrian scientists modify and reinforce host defence peptide from breast milk to detect cancer cellsScientists at the University of Graz in Austria have modified and reinforced a host defence peptide from breast milk to enable it to specifically detect cancer cells. As part of the project, which ha2017/4/17